We have previously shown that chronic mitral regurgitation (MR) increases the rate of left ventricular early diastolic filling. These changes in chamber diastolic function were felt to be secondary to alterations in left ventricular loading conditions. Therefore, cellular diastolic function measured in cardiac muscle cells (cardiocytes) isolated from animals with chronic MR (absent alterations in loading conditions) was expected to be normal. However, chronic MR caused a decrease in sarcomere lengthening rate. The purpose of the current study was to define the mechanisms causing this decreased sarcomere hcngthening rate in chronic MR cardiocytes and to explain the apparent dichotomy between chamber and cellular diastolic properties. Accordingly, sarcomere motion was measured using laser diffraction techniques in enzymatically isolated cardiocytes from seven control dogs and 11 dogs with chronic MR (produced by closed-chest transection of the mitral chordae). In the MR cardiocytes, there were abnormalities in cellular systolic function (decreased extent and velocity of shortening) and in cellular diastolic function (decreased velocity of sarcomere lengthening). Because studies in papillary muscles have shown that there is a direct relation between abnormal diastolic function (decreased velocity of muscle lengthening) and abnormal systolic function (decreased extent of muscle shortening), it was unclear whether the changes in cellular relaxation rate observed in chronic MR merely reflected a concomitant decrease in the extent of shortening or instead reflected an impairment in intrinsic relaxation properties. To make this distinction, the relation between relaxation velocity (measured as peak sarcomere lengthening rate) and sarcomere shortening extent was examined in MR cardiocytes and compared with that in control cardiocytes. There was a direct relation between sarcomere relaxation velocity and sarcomere shortening extent in both control and MR cardiocytes. Over a wide range of shortening extent, the slopes andy intercepts of this relation were similar in control and MR cardiocytes (slope, 27.7 sec`in control cells versus 28.1 sec`in MR cells; y intercept, -1.1 ,um/sec in control cells versus -1.7,um/sec in MR cells; p=NS). At any common shortening extent, relaxation velocity was the same in control and MR cardiocytes. To prove that this relation could detect abnormalities in the intrinsic myocardial relaxation process, interventions known to produce primary alterations in the intrinsic myocardial relaxation process were examined: the effects of hypothermia (30°C) and isoproterenol (10-6 M) on the relaxation velocity-shortening extent relation were studied in normal and MR cardiocytes. In normal cardiocytes, hypothermia decreased relaxation velocity at any common shortening extent and decreased the slope of this direct relation (slope, 24.4 sec`at 37°C versus 13.9 sec`at30°C;p<0.05), whereas isoproterenol increased relaxation velocity at any common shortening extent and increased the slope of this direct relation (slope, 24.5 sec`before versus 29.8 sec`during isoproterenol; p<0.05). Similarly, in MR cardiocytes, hypothermia decreased the slope of the relaxation velocity-shortening extent relation, whereas isoproterenol increased the slope of this relation. Thus, in isolated cardiocytes from both control and chronic MR dogs, there was a direct relation between sarcomere relaxation velocity and the extent of sarcomere shortening. Changes in the slope of this relation accurately reflected changes in the intrinsic myocardial relaxation process. The slope of the relation between relaxation velocity and shortening extent was the same in control cardiocytes and chronic MR cardiocytes. Thus, the abnormalities in cellular diastolic function seen in chronic MR resulted from a decrease in systolic function leading to a decrease in the extent of shortening and diminished restoring forces. Changes in cellular diastolic function did not result from a primary impairment of the intrinsic myocardial relaxation process. (Circulftion Research 1993;72:1110-1123 KEY WORDS * diastole * volume overload * hypertrophy * myocytes R ) ecent clinical and experimental studies have (LV) diastolic filling.1-5 Studies in a canine model of shown that chronic mitral regurgitation (MR) chronic MR suggested that the mechanisms causing increases the rate and extent of left ventricular these changes in chamber diastolic function were an
Effects of Chronic Mitral Regurgitation on Diastolic Function in Isolated Cardiocytes
Hiroyuki Tsutsui, Yoshitoshi Urabe, Douglas L. Mann, Hirofumi Tagawa, Blase A. Carabello, George Cooper IV, and Michael R. Zile
We have previously shown that chronic mitral regurgitation (MR) increases the rate of left ventricular early diastolic filling. These changes in chamber diastolic function were felt to be secondary to alterations in left ventricular loading conditions. Therefore, cellular diastolic function measured in cardiac muscle cells (cardiocytes) isolated from animals with chronic MR (absent alterations in loading conditions) was expected to be normal. However, chronic MR caused a decrease in sarcomere lengthening rate. The purpose of the current study was to define the mechanisms causing this decreased sarcomere hcngthening rate in chronic MR cardiocytes and to explain the apparent dichotomy between chamber and cellular diastolic properties. Accordingly, sarcomere motion was measured using laser diffraction techniques in enzymatically isolated cardiocytes from seven control dogs and 11 dogs with chronic MR (produced by closed-chest transection of the mitral chordae). In the MR cardiocytes, there were abnormalities in cellular systolic function (decreased extent and velocity of shortening) and in cellular diastolic function (decreased velocity of sarcomere lengthening). Because studies in papillary muscles have shown that there is a direct relation between abnormal diastolic function (decreased velocity of muscle lengthening) and abnormal systolic function (decreased extent of muscle shortening), it was unclear whether the changes in cellular relaxation rate observed in chronic MR merely reflected a concomitant decrease in the extent of shortening or instead reflected an impairment in intrinsic relaxation properties. To make this distinction, the relation between relaxation velocity (measured as peak sarcomere lengthening rate) and sarcomere shortening extent was examined in MR cardiocytes and compared with that in control cardiocytes. There was a direct relation between sarcomere relaxation velocity and sarcomere shortening extent in both control and MR cardiocytes. Over a wide range of shortening extent, the slopes andy intercepts of this relation were similar in control and MR cardiocytes (slope, 27.7 sec`in control cells versus 28.1 sec`in MR cells; y intercept, -1.1 ,um/sec in control cells versus -1.7,um/sec in MR cells; p=NS). At any common shortening extent, relaxation velocity was the same in control and MR cardiocytes. To prove that this relation could detect abnormalities in the intrinsic myocardial relaxation process, interventions known to produce primary alterations in the intrinsic myocardial relaxation process were examined: the effects of hypothermia (30°C) and isoproterenol (10-6 M) on the relaxation velocity-shortening extent relation were studied in normal and MR cardiocytes. In normal cardiocytes, hypothermia decreased relaxation velocity at any common shortening extent and decreased the slope of this direct relation (slope, 24.4 sec`at 37°C versus 13.9 sec`at30°C;p<0.05), whereas isoproterenol increased relaxation velocity at any common shortening extent and increased the slope of this direct relation (slope, 24.5 sec`before versus 29.8 sec`during isoproterenol; p<0.05). Similarly, in MR cardiocytes, hypothermia decreased the slope of the relaxation velocity-shortening extent relation, whereas isoproterenol increased the slope of this relation. Thus, in isolated cardiocytes from both control and chronic MR dogs, there was a direct relation between sarcomere relaxation velocity and the extent of sarcomere shortening. Changes in the slope of this relation accurately reflected changes in the intrinsic myocardial relaxation process. The slope of the relation between relaxation velocity and shortening extent was the same in control cardiocytes and chronic MR cardiocytes. Thus, the abnormalities in cellular diastolic function seen in chronic MR resulted from a decrease in systolic function leading to a decrease in the extent of shortening and diminished restoring forces. Changes in cellular diastolic function did not result from a primary impairment of the intrinsic Figure 1 . At the chamber level, chronic MR caused an increase in the LV early diastolic filling rate measured by echocardiographic techniques. In contrast, at the cellular level, chronic MR caused a decrease in the sarcomere lengthening rate measured by laser diffraction techniques. Two possible mechanisms responsible for the decreased sarcomere lengthening rate seen in chronic MR include 1) a decrease in restoring forces and 2) abnormal myocardial inactivation. [7] [8] [9] [10] [11] [12] [13] [14] [15] [16] [17] [18] Restoring forces (created by intracellular and extracellular processes and structures that act to return the LV to equilibrium volume) represent the potential energy that is produced by the deformation occurring during contraction and that is released during relaxation.9-18 Because this mechanism applies to the isolated cardiocyte, a decrease in the systolic deformation of a cardiocyte will result in a decrease in the force acting to restore the cardiocyte to its resting unstressed shape. Therefore, we hypothesized that, as the extent of systolic shortening decreased (and restoring force decreased), the rate of sarcomere lengthening would also decrease. In addition, we hypothesized that there are differences between the restoring forces present in isolated cardiocytes versus the intact LV of dogs with chronic MR. In cardiocytes isolated from dogs with chronic MR, sarcomere shortening extent is decreased because chronic MR causes a decrease in cellular contractile function.6 However, in the intact LV of dogs with chronic MR, systolic shortening can actually be increased, despite decreased chamber contractile function, because the decreased systolic load present in chronic MR increases ejection performance. 6 19 Thus, decreased restoring forces may be present in the isolated cardiocyte while increased in the intact LV. Therefore, we hypothesized that these differences in restoring forces may provide a unique explanation for the dichotomy found between cellular and chamber diastolic function in chronic MR.
In contrast, a second mechanism, abnormal myocardial inactivation, could also cause decreased sarcomere lengthening rate in chronic MR. The rate of myocardial inactivation is determined by biochemical processes leading to the detachment of crossbridges, the sequestration of myoplasmic calcium, and a reduction in the rate of crossbridge cycling.78 A change in myocardial Schematic illustration ofhypotheses tested in this study. Changes in the relation between relaxation velocity (measured as peak sarcomere lengthening rate) and the extent of sarcomere shortening were used to determine whether mitral regurgitation decreased relaxation velocity through its effects on elastic restoring forces, in which case the relaxation velocity versus extent of shortening coordinates would slide down the normal relation from A to B, or through its effects on active intrinsic relaxation processes, in which case the relaxation velocity versus extent of shortening coordinates would move from A to a different linear relation C along the dashed line.
inactivation could alter sarcomere lengthening rate independent of simultaneous changes in restoring force.
The divergent effects that these two different mechanisms would have on cellular diastolic function are illustrated in Figure 2 . If chronic MR decreased the shortening extent from A to B in Figure 2 , moving down the solid line with no change in the slope of the relaxation velocity-shortening extent relation, these data would indicate that the decrease in relaxation velocity (measured in this study as sarcomere lengthening rate) was caused by a decrease in restoring force. On the other hand, if chronic MR decreased the shortening extent from A to C in Figure 2 and caused the relaxation velocity-shortening extent relation to move from the solid to the dashed line (a decrease in slope), these data would indicate that the decrease in relaxation velocity was caused by abnormal inactivation.
The purpose of the present study was to use the relation between relaxation velocity and shortening extent to define the mechanisms causing the decreased sarcomere lengthening rate in chronic MR and to explain the apparent disparity between changes in chamber and cellular diastolic function caused by chronic MR.
Materials and Methods

Creation of Mitral Regurgitation
Mitral regurgitation was created in the closed-chest state by methods previously described in detail. 19 All animal experiments were conducted in accordance with institutional guidelines and the "Guide for the Care and Use of Laboratory Animals' (US Department of Health and Human Services, publication No.
[NIH] 86-23). Eleven adult mongrel dogs (both sexes) weighing 20-35 kg were anesthetized with droperidol/ fentanyl (Innovar-Vet) administered intravenously and with a combination of nitrous oxide and oxygen administered by inhalation. The dogs were instrumented with a pulmonary artery thermodilution Swan-Ganz catheter, an LV angiographic catheter, and a dual-tipped micromanometer catheter (Millar Instruments, Houston, Tex.). After the baseline pressure recordings, cardiac output measurements, and ventriculographic studies, MR was created via a transvascular approach. A grasping forceps was inserted into the LV from the left carotid artery. Mitral chordae tendineae were grasped and transected in successive steps until the pulmonary capillary wedge pressure increased to .20 mm Hg and forward stroke volume fell by more than 50% of its baseline value. Then the severity of regurgitation and regurgitant fraction were assessed by LV cineangiography.
Seven additional dogs underwent similar hemodynamic and angiographic studies but did not undergo creation of MR. These dogs served as a control group.
Three months after recovery from these procedures, the dogs were restudied in the same manner. After 3 months of chronic MR, the regurgitant fraction was 0.65 ±0.04; LV end-diastolic volume was increased (end-diastolic volume/body weight=3.34+0.14 ml/kg in the control group versus 4.98+0.32 ml/kg in the MR group; p<0.05); and LV mass was increased (LV weight/body weight=3.94+0.16 g/kg in the control group versus 4.61+±0.16 g/kg in the MR group;p<0.05). These data demonstrated that chronic MR induced LV volume overload hypertrophy.
Preparation of Isolated Cardiocytes
The methods used to isolate cardiocytes from the LV were previously described in detail.6,20,21 The dogs were anesthetized in the manner described above. Using a left lateral thoracotomy, the hearts were rapidly removed, placed in cold nominally calcium-free buffer solution of the following composition (mM): NaCl 130.0, KCl 4.8, MgSO4 1.2, NaH2P04 1.2, NaHCO3 2.5, HEPES 12.0, and glucose 12.5. The atria and great vessels were removed, leaving the left circumflex artery intact. A wedge of LV free wall, perfused by either the first or second branch of this artery, was dissected free of the heart. Then that arterial branch was cannulated, and the specimen was cleared of blood by perfusion with buffer warmed to 37°C and gassed with 100% 02. To dissociate the cardiocytes from the tissue, perfusion was continued for 15 minutes at 37°C by recirculating the buffers now supplemented with type II collagenase (155 units/ml); coronary perfusion pressure and pH were kept within the physiological range. After completion of the perfusion, the borders of specimen and epicardium were discarded, and the remaining myocardium was minced with scissors in fresh collagenase-containing buffer to which was added bovine serum albumin and 300 ,uM Ca2`. The minced tissue was then gently agitated for 5 minutes in the same buffer at 37°C. The cardiocytes were harvested by drawing off the supernatant in which they were suspended and filtered through 210-,m nylon mesh. They were kept in collagenase-free buffer supplemented with 2.5 mM Ca21 for 1 hour at 37°C before characterizing cellular function.
Evaluation of Sarcomere Motion and Cardiocyte Morphology
The details of the laser diffraction method used to measure systolic and diastolic function of isolated cardiocytes have been previously described in detail.6'20'21 An aliquot of cardiocytes was placed in 4 ml of the 2.5 mM Ca 2+ buffer in a well that was affixed to a glass slide. The cardiocytes were then allowed to settle down through the buffer solution onto the surface of the glass microscope slide, which rested on the stage of an inverted microscope. The temperature of the buffer was kept at 37.O±0.1°C with a thermostated heating stage. The cardiocytes were stimulated to contract between a pair of platinum wire electrodes by 0.25-Hz 100-,A direct-current pulses of alternating polarity. Changes in sarcomere length (SL) were measured from movement of the first-order diffraction pattern cast by a substage helium-neon laser light passing through the sarcomere of a given cardiocyte onto diametrically opposed optical sensors situated 2.5 cm above the microscope stage. Cardiocyte size was determined using methods previously described in detail.6'20'21
Experimental Protocol
Evaluation of cellular diastolic function in control and MR cardiocytes. Single rod-shaped cells, unattached to either adjacent cells or debris, which contracted with each stimulus and were quiescent between stimuli, were selected for measurement of sarcomere motion. The following measures of SL (in micrometers) were examined during contraction: initial SL (SL at the onset of contraction), minimum SL (smallest SL at peak contraction), the extent of sarcomere shortening (initial SL-minimum SL), peak velocity of sarcomere shortening (shortening velocity, in micrometers per second), and peak velocity of sarcomere lengthening (relaxation velocity, in micrometers per second). Cardiocyte mechanics were examined in 34 cardiocytes from seven control dogs (control cells) and 45 cardiocytes from nine chronic MR dogs (MR cells). When the shortening extent became stable after 10-15 contractions, 10 contractions were recorded and averaged to yield a final profile of sarcomere motion.
Relaxation velocity versus shortening extent relation.
Previous studies in the intact LV and isolated cardiac muscles demonstrated a dependent interaction between relaxation velocity and shortening extent, end-systolic volume, or end-systolic muscle length.7,8'12"18'22-30 Therefore, it was important to determine whether an observed change in sarcomere lengthening velocity was dependent on or independent of simultaneous changes in systolic function. Accordingly, the relation between relaxation velocity and the shortening extent was analyzed in a manner similar to that used in studies of isolated cardiac muscle25 and the intact LV. 29 The relation between relaxation velocity, minimum SL, and initial SL was also analyzed. Thirty-four cardiocytes from seven control dogs and 45 cardiocytes from nine MR dogs were used in the preliminary analysis shown in Figure 3 , most of the MR cells had smaller shortening extents than did the control cells. Thus, there was a limited range of overlap in shortening extent between these two groups of cells. Therefore, it was difficult to compare relaxation velocity in MR versus control cardiocytes over a common wide range of shortening extent, to compare the slopes, or to determine which of the hypotheses illustrated in Figure 2 (A to B versus A to C) were correct. To deal with this limitation, 30 contractions with varying extents of shortening were obtained from five cardiocytes isolated from three additional control dogs by recording monotonically increasing shortening extent during the first 15 contractions after the initiation of electrical stimulation (variable frequency or treppe effect).3' After starting electrical stimulation, the shortening extent increased beat by beat and reached a stable maximum level after an average of 15 contractions. This treppe protocol was repeated in each cell a minimum of five times. There was a 10-minute quiescent interval (no electrical stimulation) between each treppe protocol. Beats with similar shortening extent were selected from each consecutive treppe protocol and averaged to yield final sarcomere contraction profiles with successively increasing shortening extents (Figure 4 ). Control cell data from Figure 3 (constant frequency) are reproduced in Figure  5A . Control cell data from the treppe protocol (variable frequency) are shown in Figure SB . The slope of the relaxation velocity-shortening extent relation for the control cells (20 sec-1) in Figure SA (constant frequency) was similar to the slope for control cells (23 sec 1) in Figure 5B relaxation velocity-shortening extent relation was the same for both treppe and constant frequency cardiocytes, these data were combined in Figure 5C and used as the control data for the subsequent analysis.
To determine whether MR cardiocytes respond differently to variable frequency (treppe) than normal (nim) tion for normal cardiocytes (23 sec) was similar to the slope for MR cardiocytes (20 sec).
Hypothermia and isoproterenol. To confirm that the above methods would detect abnormal myocardial inactivation if it were present, the effects of two interventions (hypothermia and isoproterenol) known to produce primary alterations in intrinsic myocardial relaxation23'25'28,29'31-39 were examined in control and MR cardiocytes.
Sarcomere dynamics were evaluated at 37°C and then at 30°C in seven cells isolated from three additional normal control dogs and six cells isolated from one MR dog. By use of the treppe protocol described above, sequential contractions after the initiation of stimulation were recorded at 37°C. This protocol was repeated three times, and beats of similar extent of shortening were selected from each consecutive treppe protocol and averaged. Averages of 35 contractions from the seven normal cells and 24 contractions from six MR cells were obtained. Then, the temperature of the media was rapidly decreased to 30°C by lowering the temperature of the microscope heating stage. The treppe protocol was repeated three times on the same cardiocyte at 30WC. The effect of hypothermia on the slope of the relaxation velocity-shortening extent relation was examined in normal ( Figure 7 ) and MR cardiocytes (Figure 8 ).
Sarcomere dynamics were evaluated before and 15 minutes after isoproterenol was added to the buffer (to bring its final concentration to 10 6 M) in seven cells isolated from three normal dogs and six cells isolated from one MR dog. Treppe protocols were repeated three times on the same cell before and after the addition of isoproterenol. The effect of isoproterenol on the slope of the relaxation velocity versus the extent of shortening was examined in normal cardiocytes ( Figure  9 ) and MR cardiocytes (Figure 8 ).
It should be recognized, however, that the relaxation velocity-shortening extent relation, like all physical measurements, has limits of resolution. This relation is still undergoing evaluation and will require future studies to fully evaluate its sensitivity and specificity. However, previous studies support the validity of this method. First, ventricular and myocardial relaxation were successfully and similarly evaluated by examining the LV peak filling rate-LV end-systolic volume or -ejection fraction relation in the intact LV23,2629 and the isotonic lengthening rate-end-systolic muscle length or -extent of muscle shortening relation in isolated cardiac muscle strips. Isoproterenol caused a significant increase in the slope of both relations such that, for any common extent of shortening or minimum sarcomere length, relaxation velocity was increased during isoproterenol administration.
reliably detect them: changes in cellular relaxation caused by right ventricular pressure overload hypertrophy (pulmonary artery banding in cats) were detected using the relaxation velocity-shortening extent relation. 40 In these experiments, the relaxation velocityshortening extent relation in cardiocytes isolated from the right ventricle of cats with right ventricular pressure overload hypertrophy was shifted down and to the right, with a significant decrease in the slope compared with normal feline cardiocytes isolated from the LV of the same animals. Because of the limitation discussed above, the possibility that small but undetected changes in intrinsic relaxation may be produced by chronic MR cannot be excluded absolutely. However, and perhaps more importantly, the analytic technique used in this study may provide insight into at least one important potential mechanism causing the observed decrease in sarcomere relaxation velocity in MR cardiocytes, specifically, a decrease in shortening extent, and may help to explain the apparent differences between an increased in vivo relaxation rate in the intact dog and the decreased relaxation rate in vitro in the cardiocyte.
Determinants of relaxation velocity. Studies in isolated papillary muscles, in the intact LV, and in humans have demonstrated that the primary hemodynamic and mechanical determinants of LV early diastolic filling rate and muscle lengthening rate include changes in preload, afterload, and late load.7'8 '26,27,41 Because these concepts apply to sarcomere relaxation velocity, it was hypothesized that three of the possible primary determinants of relaxation velocity included initial SL, minimum SL, and extent of sarcomere shortening. The constraints of the experimental design used in the current study did not allow independent control of these three variables. Therefore, direct prospective comparisons between initial SL, minimum SL, and extent of shortening as primary determinants of relaxation velocity could not be made. However, retrospective matching of contractions was performed in an effort to hold one of these three variables relatively constant (or at least within a narrow specified range) while allowing the other two parameters to vary randomly. In protocol 1, initial SL was limited to a specified range while minimum SL and extent of shortening were variable; in protocol 2, minimum SL was limited to a specified range while initial SL and extent of shortening were variable; in protocol 3. extent of shortening was limited to a specified range while initial SL and minimum SL were variable. It was believed that these protocols would allow us to determine if one or more of these variables is an independent primary determinant of relaxation velocity. It should be noted, however, that in each protocol the parameters that are variable are not necessarily independent of each other. For example, in protocol 1 the changes in extent of shortening are proportional to the changes in minimum length (and vice versa).
Data Analysis
Data are presented as mean+SEM. Differences in selected measurements between control and MR were evaluated by an unpaired Student's t test with a Bonferroni correction for multiple comparisons between groups. The slope and y intercept of the relaxation velocity-initial length, -minimum length, or -shortening extent relation were calculated using a least-squares linear fit analysis. For linear regression data, the significance of the correlation coefficient was assessed by a t test. Differences in slopes and y intercepts between groups were assessed by an analysis of variance of regression. Differences were considered statistically significant at p< 0.05.
Results
Characterization of the Experimental Model
Morphological studies of LV cardiocytes demonstrated that the length, width, and surface area of MR cardiocytes were significantly increased compared with control cardiocytes (Table 1) . Laser diffraction studies demonstrated that the initial SL was similar in both groups of cells; relaxation velocity, shortening extent, and shortening velocity were significantly less in the MR cells than in control cells.
Relaxation Velocity Versus Initial SL There was no significant relation between relaxation velocity and initial SL in either the control or MR cells (Figure l0A ). Attempted linear fit resulted in values of r<0.40 andp>0.05.
Relaxation Velocity Versus Minimum SL
There was an inverse relation between relaxation velocity and minimum SL in both the control and MR cells (Figure lOB) ; relaxation velocity slowed as minimum SL increased. There were no significant differences in the slope and y intercept between control and MR cells. The slope was -10.1 sec`1 in control cells versus -11.0 sec`in MR cells; they intercept was 20.8 ,um/sec in control cells versus 21.4 gm/sec in MR cells (both p=NS). However, there was more dispersion around this relation in control cells (correlation coefficient, r=0.50) and MR cells (r=0.50) than the relation between relaxation velocity and shortening extent in control cells (r=0.87) and MR cells (r=0.79). The cause of this dispersion was suspected to be the variability in initial SLs between cells (see further analysis below).
Relaxation Velocity Versus Shortening Extent
There was a direct relation between relaxation velocity and shortening extent in both the control and MR cells ( Figure 10C ); relaxation velocity slowed as the shortening extent fell. Over a wide range of the extent of shortening, the relaxation velocity-shortening extent coordinates in the MR cells fell along a common relation with the control cells. At any common shortening extent, relaxation velocity was the same in control and MR cells. There were no significant differences between the slopes and y intercepts of this relation in control cells versus 28.0 sec`in MR cells; the y intercept was -1.1 gm/sec in control cells versus -1.6 gm/sec in MR cells (both p=NS).
Effects of Hypothermia and Isoproterenol (Normal Cardiocytes)
Hypothermia (30°C) resulted in a decreased relaxation velocity at any given extent of shortening or minimum SL (Figure 7) . Hypothermia decreased the slope of the direct relation between relaxation velocity and shortening extent from 24.4 sec`1 at 37°C to 13.8 sec-1 at 30°C (p<0.05). Likewise, hypothermia decreased the slope of the inverse relation between relaxation velocity and minimum SL from -18.2 sec`1 at 37°C to -10.4 sec-1 at 30°C (p<0.05).
In contrast, isoproterenol (10 6 M) increased relaxation velocity at any given shortening extent or minimum SL (Figure 9 ). Isoproterenol increased the slope of the relation between relaxation velocity and shortening extent from 24.5 sec`1 at baseline to 29.1 sec`1 during isoproterenol administration (p<0.05). Likewise, isoproterenol increased the slope of the inverse relation between relaxation velocity and minimum SL from -16.6 sec`at baseline to -25.4 sec`1 during isoproterenol administration (p<0.05).
Effects of Hypothermia and Isoproterenol (MR Cardiocytes)
Hypothermia (30°C) resulted in a decreased relaxation velocity at any given shortening extent (Figure 8 ). The slope of the relaxation velocity-shortening extent relation fell from 19.6 sec-1 at 37°C to 13.8 sec`at 30°C (p<0.05). In contrast, isoproterenol (10-6 M) increased the relaxation velocity at any given shortening extent (Figure 8 ). The slope of the relaxation velocity-shortening extent relation increased from 19.6 sec`1 at baseline to 24.8 sec`1 during isoproterenol administration (p<O.O5).
Primary Determinant of Relaxation Velocity: Comparison of Initial SL, Minimum SL, and Extent of Shortening
Constant initial length (protocol 1). Thirty-nine of 64 control contractions and 33 of 45 MR contractions had an initial SL between 1.8 and 1.9 gim. Figure 11 demonstrates the relaxation velocity-initial SL, -minimum SL, and -shortening extent relation for these contractions. Like the entire data base (shown in Figure  10 ), Figure 11 demonstrates that there was a direct relation between relaxation velocity and shortening extent (r=0.87 in control cells, r=0.82 in MR cells) and an inverse relation between relaxation velocity and minimum length (r=0.73 in control cells, r=0.72 in MR cells). There were no differences in slope or y intercept between the groups in either relation. In Figure 11 , there was less dispersion and variability around the relaxation velocity-minimum SL relation than in Figure 10 . We suspected that the cause of the dispersion in Figure 10 was the variability in the initial SL between cells in each group. Data presented in Figure 11 suggest and confirm that, when the relaxation velocity-minimum SL relation was reexamined using control and MR cells with matched (or comparable) initial SL, coordinates were more tightly grouped around the inverse relation. It should be noted, how-ever, that when the initial sarcomere length was limited to a specified range, the observed changes in minimum length corresponded directly with changes in shortening extent.
Constant minimum length (protocol 2). Twenty of 64 control contractions and 16 of 45 MR contractions had a minimum SL between 1.65 and 1.7 gim. Figure 12 shows the relation between relaxation velocity and initial SL, minimum SL, and shortening extent for these contractions. Like the entire data base (shown in Figure  10 ), there was no significant relation between relaxation velocity and initial SL, but there was a direct relation between relaxation velocity and shortening extent (r=0.76 in control contractions, r=0.75 in MR contractions). There were no differences in slope ory intercept between the two groups of cells.
Constant extent of shortening (protocol 3). Twentyeight of 64 control and 11 of 45 MR contractions had a shortening extent between 0.17 and 0.21 gim. Figure 13 shows the relation between relaxation velocity and initial SL, minimum SL, and shortening extent. Unlike the entire data base (shown in Figure 10 ) and in contrast to protocol 1, this analysis failed to demonstrate a significant relation between relaxation velocity and minimum SL. When shortening extent was limited to a specified range and initial SL and minimum SL were allowed to vary (i.e., when changes in minimum SL was dissociated from changes in shortening extent), minimum SL failed to have an independent effect on relaxation velocity.
Discussion
The purpose of the current study was to define the mechanisms causing the decreased sarcomere lengthening rate in chronic MR and to explain the apparent dichotomy between changes in chamber and cellular diastolic function produced by chronic MR. To accomplish this goal, three steps were taken: 1) The primary determinants of sarcomere relaxation velocity were identified. 2) A method was developed to distinguish between alterations in sarcomere relaxation velocity caused by a change in the intrinsic active relaxation process versus a change in restoring force. 3) This method was used to define and explain the changes in cellular diastolic function produced by chronic MR. Data from this study support three major new conclusions. First, both sarcomere shortening extent and minimum SL affect relaxation velocity, but shortening extent is the major independent determinant. Second, there is a direct relation between maximum sarcomere relaxation velocity and sarcomere shortening extent. The slope of this relation is sensitive to and dependent on changes in the rate of myocardial inactivation. The slope of this relation fell when cardiocytes were exposed to hypothermia (an intervention that decreases myocardial inactivation rate); the slope of this relation increased when cardiocytes were exposed to isoproterenol (an intervention that increases myocardial inactivation rate). After it was demonstrated that the relaxation velocity-shortening extent relation was sensitive to primary alterations in inactivation rate, this method was then applied to cardiocytes isolated from dogs with chronic MR. The relaxation velocity-shortening extent coordinates in MR cardiocytes fell along a common relation with normal cardiocytes; the slope of this relation was the same in both normal and MR cardiocytes. These data led to the third conclusion: there is no real dichotomy between chamber and cellular diastolic function in chronic MR. The current study demonstrated that the sarcomere lengthening rate is decreased in chronic MR because of and in proportion to a decrease in sarcomere shortening (and a resultant decrease in restoring forces) and not consequent to a primary impairment in the rate of myocardial inactivation. Previous studies have demonstrated that the LV early diastolic filling rate is increased in chronic MR because of changes in LV loading conditions (including an increase in restoring forces) and is not consequent to a primary change in the rate of myocardial inactivation. 3, 4 Thus, the dichotomy in restoring forces (and LV load) explains the apparent dichotomy in chamber versus cellular diastolic function in chronic MR.
Measurement of Cellular Relaxation Velocity
In the intact LV (and physiologically sequenced isolated cardiac muscles), active myocardial relaxation is characterized by isovolumic pressure (or isometric force) decline followed by early diastolic filling (or isotonic muscle lengthening). In contrast, in unattached, freely shortening isolated cardiocytes, there is no isometric phase of relaxation. Therefore, active relaxation in an isolated cardiocyte is quantified by measuring the velocity of cell or sarcomere lengthening. The process of cardiocyte sarcomere lengthening after electrical or chemical stimulation has been characterized as having two phases: an early rapid phase and a later slower phase of lengthening. 15"16'42 The determinants of each of these two phases are postulated to be distinct and different. The rapid phase may be largely determined by the rate of myocardial inactivation and by changes in restoring forces. 9, 13, 14, 17, 31, 43 The later phase may be largely dependent on the rapidity with which the sarcolemmal sodium-calcium exchanger decreases intracellular calcium concentration. 15, 42 Changes in intracellular calcium concentrations produced by the sarcolemmal sodium-calcium exchanger are thought to affect late diastolic events (such as LV end-diastolic pressure) and, only to a lesser degree, early diastolic events (such as peak filling rate). 42 The focus of the present study was to determine why the early LV filling rate was increased while the early rapid sarcomere lengthening velocity EXTENT OF SHORTENING ( gm) was decreased in chronic MR. Thus, the measurements made, results presented, and discussion that follows focus on early rapid sarcomere lengthening events and their determinants.
Determinants of Cellular Relaxation Velocity
The approach used in this study to define the determinants of sarcomere lengthening rate was based on previous work in the intact LV and in isolated cardiac muscle.7 '8"1214'22-30,41 These studies demonstrated that the rate of active relaxation is determined by myocardial inactivation rate, as well as systolic and diastolic loading conditions. Myocardial inactivation is determined by energy-dependent biochemical processes (which cause crossbridge detachment, sarcoplasmic reticulum calcium sequestration, and reduction in crossbridge cycling rate). Systolic loading conditions and their effect on systolic deformation determine restoring forces (created by intracellular and extracellular processes or structures that act to return the LV to equilibrium volume or unstressed length). Diastolic loading conditions represent the external forces that promote filling (such as the left atrial-LV transmitral pressure gradient and stress at mitral valve opening). Likewise, the process of car-diocyte and sarcomere lengthening is influenced and determined by both active and passive cellular processes. In this study, these determinants were divided into those processes that were predominantly passive ("restoring force") and those processes that were predominantly active ("intrinsic relaxation"). It should be recognized that this division is somewhat arbitrary and may be oversimplified. Restoring forces are composed of those active and passive processes that promote lengthening and are dependent on the extent of cell or sarcomere shortening or the minimum end-systolic length. In contrast, intrinsic relaxation is composed of those active and passive processes that promote lengthening but are independent of shortening extent or end-systolic length.
LV early diastolic filling rate is determined by changes in systolic loading conditions that affect end-systolic volume, end-systolic stress, and ejection fraction (factors that reflect and affect passive elastic restoring forces), by changes in diastolic loading conditions (such as the transmitral pressure gradient), and by changes in inactivation rate (such as those caused by hypoxia, hypothermia, and 3-adrenergic agonists/antagonists). 7, 8, 26, 27, 41 It has been shown that there is a linear relation between Data presented in the current study are concordant with these previous studies in the intact LV and isolated muscles. In addition, these data are concordant with previous studies in isolated cardiocytes that suggested that the rate of cell or sarcomere lengthening is dependent, at least in part, on SL.9 -3,14,17,43 Studies in isolated cardiocytes demonstrated that relaxation velocity increased as the extent of sarcomere shortening increased and SL itself decreased.'3'14"7 Although length-depen-dent deactivation may play a role in the increased relaxation velocity seen at smaller SLs, a recent study by Niggi and Lederer17 demonstrated that restoring forces were present in isolated cardiocytes and that these restoring forces were independent of myofibril sensitivity to calcium. Although the source of restoring forces remains speculative, the presence and importance of restoring forces appears to be well established. Studies by ter Keurs et a19 suggest that the sources of restoring forces include passive elastic elements, repulsive forces between thick and thin filaments, and forces resulting from deformation of thick and thin filaments. In addition, Krueger15 suggests that restoring forces are based not only on changes in contractile proteins during contraction but also on noncontractile proteins such as cytoskeletal proteins, which may be deformed during contraction. Whereas cytoskeletal and contractile proteins may be the source of restoring forces within the cardiocyte, in multicellular preparations such as cardiac muscle strips and the LV itself, restoring forces are also produced by the complex protein structure of the extracellular matrix and cell-to-cell attachments.
The current study addresses, in part, which SL measurements are most closely related to changes in relaxation velocity and thus best reflect changes in restoring forces. Initial SL, minimum were examined. Initial SL did not affect sarcomere lengthening velocity. These data are concordant with previous studies in the LV and in papillary muscles, which showed that preload (end-diastolic volume, pressure, or stress) did not affect the rate of isovolumic pressure (or force) decline or the rate of peak early diastolic filling (or muscle lengthening). 25.44-48 Data from the current study suggest that both minimum SL and shortening extent affect relaxation velocity. These data are concordant with studies in both the intact LV and in isolated muscles.78262 741 Which of these two factors is the most important determinant may depend on the preparation being studied. In multicellular preparations, the extracellular matrix tends to hold initial SL uniform within and between cells. In contrast, initial SL varies in isolated cardiocytes. Restoring force within an isolated cardiocyte is dependent on how much internal deformation occurs during contraction. In multicellular preparations, restoring force is dependent on an interaction between internal deformation and deformation of the protein matrix outside the cell. In multicellular preparations (as in protocol 1 in this study), since initial SL was limited within a narrow range, there was a direct relation between minimal SL and shortening extent. If preload is increased, the extent of shortening increases, but the muscle shortens to the same minimum SL. Restoring force remains the same at differing preloads, since initial SLs are increased beyond equilibrium length. Restoring forces are proportional to deformation from equilibrium length. Thus, minimum muscle length appears to be the primary determinant of myocardial relaxation velocity in isolated muscle and in the intact LV, whereas the extent of sarcomere shortening is the primary determinant of relaxation velocity in the isolated cardiocyte.
Effects of Chronic MR on Chamber Diastolic Function
A variety of clinical and experimental studies show that chronic MR causes an increase in the rate and extent of LV early diastolic filling.1-5 In the intact LV, two sets of loading conditions (which are not present in isolated cardiocytes) act as determinants of peak filling rate: systolic load (stress throughout contraction) and early diastolic load (left atrial to left ventricular transmitral pressure gradient present during early rapid filling).3'4 In chronic MR, Katayama et a13 suggested that the increased extent and rate of filling is caused by decreased systolic load, which resulted in an increased systolic shortening, increased early diastolic chamber elastance, and increased elastic recoil. In addition to these factors, our previous study demonstrated that an increased transmitral pressure gradient and an increased left atrial driving force were principal causes of an increased peak filling rate in chronic MR. Neither of these studies suggested that there were any changes in myocardial inactivation rate, which contributed to the increased peak filling rate. Thus, these studies in chronic MR demonstrated that, in vivo, restoring force is increased in the intact LV, whereas the present study has shown that, in vitro, restoring force is decreased in the isolated cardiocyte. This dichotomy between in vivo and in vitro restoring forces resolves the apparent dichotomy in chamber versus cellular diastolic function. However, the next question is this: What causes this difference in restoring force? The answer to this question is based on the unusual LV systolic loading conditions that are present in chronic MR. Our previous study clearly demonstrated that the in vivo LV chamber contractile state is decreased in chronic MR.6,19 However, the low impedance left atrial leak present in chronic MR acts to "unload" the LV during systole and allows the LV to maintain normal ejection performance. Thus, in vivo, LV total stroke volume and shortening extent are increased (thereby causing increased restoring force) even in the presence of a decreased contractile state.
Our previous study demonstrated that the in vitro cellular contractile state was also decreased in chronic MR.6 However, in the isolated cardiocyte there are no external forces that serve to "counteract" these changes in the contractile state. Thus, a decrease in the cellular contractile state is accompanied by a decrease in the shortening extent and therefore a decrease in restoring force.
Conclusions
Sarcomere lengthening rate is decreased in chronic MR because there is a decrease in restoring force not because there is a change in intrinsic relaxation processes. These abnormalities in relaxation velocity are not noted in the intact LV because in vivo loading conditions preserve ejection performance, increase the restoring force, and increase the transmitral pressure gradient; each of these factors contributes to an increase in the rate of LV early diastolic filling.
